Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey J Langer

Showing results (51-60 of 225) with videos related to

Pageof 23
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Targeting anemia in patients with lung cancerJeffrey Crawford, Paris A Kosmidis, Fred R Hirsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2004
Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role? Focus on Eastern Cooperative Oncology Group study 2598Corey J Langer, Patricia Stephenson, Ann Thor, et al.
Cancer Investigation|December 5, 2014
Warthin's tumors and their relationship to lung cancerChristine Klimowicz White, Kimberly A Williams, Jorge Rodriguez-Figueroa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
The evolving role of histology in the management of advanced non-small-cell lung cancerCorey J Langer, Benjamin Besse, Antonio Gualberto, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Advanced Non-Small Cell Lung Cancer: Sequencing Agents in the EGFR-Mutated/ALK-Rearranged PopulationsEric K Singhi, Leora Horn, Lecia V Sequist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2004
Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapyAthanassios Argiris, Yi Li, Barbara A Murphy, et al.
Clinical Lung Cancer|January 10, 2015
Weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: analysis of safety and efficacy in patients with renal impairmentCorey J Langer, Vera Hirsh, Amy Ko, et al.
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Targeted molecular mechanisms of epoetin alfaCorey J Langer, Fred R Hirsch, Hernan Cortés-Funes, et al.
The Oncologist|April 14, 2018
Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung CancerChia-Yu Chu, Jennifer Choi, Beth Eaby-Sandy, et al.
Clinical Lung Cancer|November 30, 2020
Immunotherapy Treatment Patterns and Outcomes Among ALK-Positive Patients With Non-Small-Cell Lung CancerMohammad Jahanzeb, Huamao M Lin, Xiaoyun Pan, et al.
Pageof 23

Showing results (51-60 of 225) with videos related to

Sort By:
Pageof 23
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Targeting anemia in patients with lung cancerJeffrey Crawford, Paris A Kosmidis, Fred R Hirsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2004
Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role? Focus on Eastern Cooperative Oncology Group study 2598Corey J Langer, Patricia Stephenson, Ann Thor, et al.
Cancer Investigation|December 5, 2014
Warthin's tumors and their relationship to lung cancerChristine Klimowicz White, Kimberly A Williams, Jorge Rodriguez-Figueroa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
The evolving role of histology in the management of advanced non-small-cell lung cancerCorey J Langer, Benjamin Besse, Antonio Gualberto, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Advanced Non-Small Cell Lung Cancer: Sequencing Agents in the EGFR-Mutated/ALK-Rearranged PopulationsEric K Singhi, Leora Horn, Lecia V Sequist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2004
Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapyAthanassios Argiris, Yi Li, Barbara A Murphy, et al.
Clinical Lung Cancer|January 10, 2015
Weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: analysis of safety and efficacy in patients with renal impairmentCorey J Langer, Vera Hirsh, Amy Ko, et al.
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Targeted molecular mechanisms of epoetin alfaCorey J Langer, Fred R Hirsch, Hernan Cortés-Funes, et al.
The Oncologist|April 14, 2018
Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung CancerChia-Yu Chu, Jennifer Choi, Beth Eaby-Sandy, et al.
Clinical Lung Cancer|November 30, 2020
Immunotherapy Treatment Patterns and Outcomes Among ALK-Positive Patients With Non-Small-Cell Lung CancerMohammad Jahanzeb, Huamao M Lin, Xiaoyun Pan, et al.
Pageof 23